Skip to main content
Clinical Trials/NCT02420288
NCT02420288UnknownNot Applicable

Effect of Physical Exercise Program on Fetoplacental Growth: a Randomized Controlled Trial

Universidad Politecnica de Madrid1 site in 1 country124 target enrollmentStarted: November 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
124
Locations
1
Primary Endpoint
Placental weight

Study Overview

Brief Summary

The aim of this study is to examine the effect of a supervised physical exercise program during pregnancy on fetoplacental growth.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Being healthy and able to exercise following American College of Obstetricians and Gynecologists (ACOG) guidelines
  • •Being able to communicate in spanish
  • •Giving birth at Hospital Universitario de Torrejón, Hospital Universitario de Puerta de Hierro or Hospital Universitario Severo Ochoa (Madrid)

Exclusion Criteria

  • •Multiparity
  • •Obstetrician complications
  • •Being interested in the study after 18 weeks
  • •Not having availability to attend to the physical exercise program
  • •Younger than 18 years old
  • •Older than 45 years old

Arms & Interventions

Control Group

No Intervention

Pregnant women not participating in supervised physical exercise program. The subjects in this group will be monitored during pregnancy to know if they make any kind of exercise on your own, to know which are really sedentary pregnant women.

Exercise Group

Experimental

Pregnant women participating in supervised physical exercise program.

Intervention: Exercise Group (Behavioral)

Outcomes

Primary Outcomes

Placental weight

Time Frame: At delivery

Fetal birth weight

Time Frame: At delivery

Change from baseline in maternal gestational weight

Time Frame: 38-42 weeks of gestation

Maternal weight gain during pregnancy. Weight will be measured at the beginning and at the end of the pregnancy

Secondary Outcomes

  • Fetal size outcomes(At delivery)
  • Maternal delivery outcomes (composite)(At delivery)
  • Changes from baseline in prenatal depression(Up to 36 weeks)
  • Pregestational weight and Body Mass Index (BMI)(Before pregnancy)
  • pH umbilical cord(At delivery)
  • Apgar score(At delivery)
  • Changes from baseline in maternal quality of life(Up to 36 weeks)
  • Gestational diabetes(24-28 weeks)
  • Fetal glycemia level(At delivery)
  • Postpartum depression(0-12 postpartum months)
  • Changes from baseline in urinary incontinence(Up to 36 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Marina Vargas Terrones

PhD student

Universidad Politecnica de Madrid

Study Sites (1)

Loading locations...

Similar Trials